First Financial Bankshares enters its Q2 earnings release — scheduled for after the close on July 16 — with short sellers having rebuilt positions over the past week even as options traders lean unusually bullish.
The most striking tension in the positioning data is the divergence between short interest and options sentiment. Short interest climbed roughly 8% over the week to 6.1% of the free float — around 8.6 million shares — after jumping sharply on July 9. That is the highest level since mid-June and puts it back near the upper end of its recent range. Yet the options market is telling the opposite story: the put/call ratio dropped to 0.22 on July 14, nearly 2.5 standard deviations below its 20-day average of 0.27. That is the most call-heavy options posture of at least the past month, pointing to a concentrated bet on upside into the print. Borrow conditions do nothing to explain the short rebuild as a squeeze risk — availability runs at roughly 1,469%, meaning lenders have more than fourteen times the shares already borrowed sitting available for new shorts. Cost to borrow has edged up 15% on the week to 0.45%, but that remains firmly in low-cost territory. Shorts face no meaningful friction here; those rebuilding positions did so by choice, not necessity.
The Street sits in a cautious-to-flat posture, though there are divergent signals worth watching. Cantor Fitzgerald's Dave Rochester lifted his price target to $35 from $34 this morning while keeping a Neutral rating — a small upward nudge that still leaves the target below the current price of $34.64. Benchmark initiated coverage in late June with a Buy and a $39 target. KBW, which has been the most consistent voice on this name, carried a Market Perform through much of 2025 with targets that drifted down from $41 to $34; the consensus mean now sits at $36.20, implying limited upside from here. The valuation picture has quietly re-rated higher over the past month: the P/E multiple expanded by about 0.8 turns to 16.3x and price-to-book moved to 2.2x, up roughly 0.1 turns. Neither level looks stretched for a high-quality Texas franchise, but the expansion comes into a print — not after one. Factor scores are mixed: the analyst recommendation divergence ranks in the 91st percentile (suggesting the sell-side skews more positively than peers), and the dividend score lands at the 90th percentile, but the short-score rank is a low 7th percentile, meaning most comparable names are less shorted. EPS momentum over 30 days ranks a weak 25th percentile, though the 90-day read is a more comfortable 65th.
The earnings reaction history offers a useful frame. The two most recent prints both produced positive day-one moves — the April 2026 report generated a 4.3% gain on the day and held most of that into the five-day window. The January 2026 print delivered a 2.1% gain on the day and then extended strongly to +9.5% over the following week. The one outlier in the data was a non-earnings event in late April that produced a -1.8% one-day slip. Short sellers who rebuilt positions this week are clearly not betting on a repeat of those post-earnings rallies.
BlackRock added 679,000 shares in Q2, bringing its stake to 12% of shares outstanding — the largest single holder and a meaningful vote of confidence from the biggest passive buyer in the market. State Street added 380,000 shares in the same period. Insider activity has been modest but directionally positive: the lead independent director made two separate open-market purchases at $29.32 and $33.18 in the past four months, and net insider buying over 90 days totals roughly 3,200 shares at a net cost of just under $100,000. None of these are large enough to move markets, but the direction is consistent.
The July 16 print is the natural resolution point: whether the options market's call-heavy posture or the short sellers' rebuilt conviction proves better-calibrated is what this week ultimately comes down to.
See the live data behind this article on ORTEX.
Open FFIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
